Drug Trial Radar · NCT05655182
A Study of BLB-201 RSV Vaccine in Infants and Children
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
137
Planned (sponsor's estimate)
Start
Mar 9, 2023
Primary completion
Dec 30, 2028
Study completion Dec 30, 2028
Sponsor
- Lead sponsor
- Blue Lake Biotechnology Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 5 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 months of age) who may or may not have had prior respiratory syncytial virus (RSV) infection.
Conditions
- Respiratory Syncytial Virus Infections
Interventions
PIV5-vectored RSV Vaccine (BLB-201) Low DoseBiological
BLB201 10\^6 PFU
PIV5-vectored RSV Vaccine (BLB-201) High DoseBiological
BLB201 10\^7 PFU
PlaceboDrug
The placebo used for the trial will be the same as the diluent (0.9% sterile saline) used for the low dose group (10\^6 PFU).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Solicited Adverse EventsTime frame: Day 1-15
- Unsolicited Adverse EventsTime frame: Day 1-29
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Paradigm Clinical Research
La Mesa, California · Recruiting
Paradigm Clinical Research - Modesto
Modesto, California · Recruiting
University of California, San Diego
San Diego, California · Recruiting
Paradigm Clinical Research Centers, LLC - Colorado, 1550 South Potomac Street, Suite 340
Aurora, Colorado · Recruiting
Emory Children's Center- Vaccine Research Clinic
Atlanta, Georgia · Recruiting
Velocity Clinical Research, Boise
Meridian, Idaho · Completed
Clinical Research Prime
Rexburg, Idaho · Recruiting
AMR Newton
Newton, Kansas · Recruiting
Velocity Clinical Research - Lafayette
Lafayette, Louisiana · Completed
Michigan Institute of Research
Allen Park, Michigan · Recruiting
Velocity Clinical Research, Grand Island
Grand Island, Nebraska · Recruiting
Be Well Clinical Studies
Lincoln, Nebraska · Recruiting
Velocity Clinical Research, Cleveland
Beachwood, Ohio · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Tribe Clinical Research, LLC Parkside Pediatrics Verdae
Greenville, South Carolina · Recruiting
Tribe Clinical Research, LLC Parkside Pediatrics
Greenville, South Carolina · Recruiting
Velocity Clinical Research, Austin
Cedar Park, Texas · Active not recruiting
Baylor College of Medicine
Houston, Texas · Active not recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.